content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001782338</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001706431</issuerCik>
        <issuerName>Vir Biotechnology, Inc.</issuerName>
        <secFileNumber>001-39083</secFileNumber>
        <issuerAddress>
          <com:street1>499 ILLINOIS STREET</com:street1>
          <com:street2>SUITE 500</com:street2>
          <com:city>SAN FRANCISCO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94158</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>415-906-4324</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>SVF Endurance (Cayman) Ltd</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Shareholder</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Class A</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Merrill</name>
          <address>
            <com:street1>555 California Street Floor 18</com:street1>
            <com:city>San Francisco</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>94104</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>915996</noOfUnitsSold>
        <aggregateMarketValue>22799140.44</aggregateMarketValue>
        <noOfUnitsOutstanding>133976538</noOfUnitsOutstanding>
        <approxSaleDate>05/19/2023</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Class A</securitiesClassTitle>
        <acquiredDate>01/03/2019</acquiredDate>
        <natureOfAcquisitionTransaction>Private Placement</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>915996</amountOfSecuritiesAcquired>
        <paymentDate>01/03/2019</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <remarks>Please see attachments for securities sold in previous three months.</remarks>
      <noticeSignature>
        <noticeDate>05/19/2023</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>04/17/2023</planAdoptionDate>
        </planAdoptionDates>
        <signature>Amanda Sanchez-Barry</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2979}]
text: 144
  0001782338
  XXXXXXXX
  LIVE
  0001706431
  Vir Biotechnology, Inc.
  001-39083
  499 ILLINOIS STREET
  SUITE 500
  SAN FRANCISCO
  CA
  94158
  415-906-4324
  SVF Endurance (Cayman) Ltd
  Shareholder
  Class A
  Merrill
  555 California Street Floor 18
  San Francisco
  CA
  94104
  915996
  22799140.44
  133976538
  05/19/2023
  NASDAQ
  Class A
  01/03/2019
  Private Placement
  Issuer
  N
  915996
  01/03/2019
  Cash
  Y
  Please see attachments for securities sold in previous three months.
  05/19/2023
  04/17/2023
  Amanda Sanchez-Barry